Traders Bet Inflation Could Surge Past 5 This Year as April Data Accelerates Cramer Backs Nvidias AI Chip Sales to China Says Stock Can Thrive Either Way Synthetic GJR Stalls at 2471 Breakout or Breakdown 20260514 Park PARK Climbs 083 Resistance at 1904 in Focus 20260517 Red Light Therapy Gains Traction as a Wellness Trend Drawing Investor Interest Apogee Thera APGE Reports Strong Q1 2026 Revenue NA EPS Beats Deloitte Integrates Blocknative Team as Crypto Infrastructure Sector Consolidates Berkshire Hathaway Adds Major Stakes in Delta Air Lines and Boosts Alphabet Position Morrisons Announces Plans to Close 100 Stores Amid Rising Cost Pressures SP 500 Edges Higher as Tech Surge Offsets Broad Weakness SpaceX OpenAI Anthropic FirstDay Trading Valuations Could Surpass Berkshire Hathaway Polymarket Data Suggests Nvidias Annual Spending on Taiwan AI Suppliers Could Reach 150 Billion Says Jensen Huang Breakout Stocks Identified by Choice Broking Analyst Amid Indian Market Decline Amazon Reports RecordBreaking Thanksgiving Holiday Week Sales Franklin Resources Inc Q1 2026 Earnings EPS Surges Past Estimates on Improved Operating Performance CG Q1 2026 Earnings Earnings Miss Expectations Despite Modest Stock Gain INVO Fertility Inc IVF Q3 2025 Earnings Significant EPS Miss No Revenue Reported AZTR Q1 2026 Earnings Massive EPS Miss Exceeds Expectations as Stock Declines Nearly 4 EWTX Q1 2026 Earnings EPS Beats Estimates as Clinical Pipeline Progresses Piper Sandler Warns Prolonged Strait of Hormuz Closure Could Drive Oil to New Summer Highs BP Q1 2026 Earnings Earnings Beat Estimates Amid Weaker Market Sentiment GPMT Q1 2026 Earnings NarrowerThanExpected Loss Signals Potential Stabilization BMBL Q1 2026 Earnings EPS Surges Past Estimates with 224 Beat PSTV Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Clinical Development Hooker Furnishings HOFT Q1 2026 Earnings EPS Misses Estimates Stock Gains on Resilient Demand OPLN Q1 2026 Earnings EPS Surpasses Estimates with 1243 Beat SAN Q1 2026 Earnings EPS Beats Estimates by 31 Shares Rally Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline